Effect of grapefruit juice on the pharmacokinetics of microemulsion cyclosporine and its metabolite in healthy volunteers: Does the formulation difference matter?

Journal of Clinical Pharmacology

Volumn 38, Issue 10, 1998, Pages 959-965

  Ku, Yi Min ^a   Min, David I ^a   Flanigan, Michael ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; WATER;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG FORMULATION; FEMALE; FRUIT JUICE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HYPOTHESIS; MALE; MICROEMULSION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; VOLUNTEER;

EID: 0031784578     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1998.tb04393.x     Document Type: Article

References (27)

1. Ducharme MP, Warbasse LH, Edwards DJ: Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharmacol Ther 1995;57:485-491.
2. Min DI, Ku Y, Perry PJ, Ukah FO, Ashton K, Martin MF, et al: Effect of grapefruit juice on cyclosporine pharmacokinetics in renal transplant patients. Transplantation 1996;62:123-125.
3. Bailey DG, Arnold JM, Munoz C, Spence JD: Grapefruit juicefelodipine interaction: mechanism, predictability, and effect of naringin. Clin Pharmacol Ther 1993;53:637-642.
4. Lown KS, Bailey DG, Fontana RJ, Janardan SK, Adair CH, Fortlage LA, et al: Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 1997;99:2545-2553.
5. Kupferschmidt HH, Ha HR, Ziegler WH, Meier PJ, Krähenbühl S: Interaction between grapefruit juice and midazolam in humans. Clin Pharmacol Ther 1995;58:20-28.
6. Benton RE, Honig PK, Zamani K, Cantilena LR, Woosley RL: Grapefruit juice alters terfenadin pharmacokinetics resulting in prolongation of repolarization on the electrocardiogram. Clin Pharmacol Ther 1996;59:383-385.
7. Fuhr U, Harder S, Lopez-Rojas P, Muller-Peltzer H, Kern P, Staib AH: Increased verapamil concentrations in steady state by coadministration of grapefruit juice (abstract). Naunyn Schmiedebergs Arch Pharmacol 1994;349:R134.
8. Ameer B, Weintraub RA: Drug interactions with grapefruit juice. Clin Pharmacokinet 1997;33:103-121.
9. Bailey DG, Arnold JMO, Strong HA, Munoz C, Spence JD: Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics. Clin Pharmacol Ther 1993;54:589-594.
10. Fahr A: Cyclosporine clinical pharmacokinetics. Clin Pharmacokinet 1993;24:472-495.
11. Kolars JC, Awni WM, Merion RM, Watkins PB: First-pass metabolism of cyclosporine by the gut. Lancet 1991;338:1488-1490.
12. Tjia JF, Webber IR, Back DT: Cyclosporine metabolism by the gastrointestinal mucosa. Br J Clin Pharmacol 1991;3:344-346.
13. Hebert MF, Robert JP, Prueksaritanont T, Benet LZ: Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction. Clin Pharmacol Ther 1993;52:453-457.
14. Min DI: Neoral: a new microemulsion cyclosporine. J Transplant Coordination 1996;6:5-8.
15. Kovarik JM, Mueller EA, vanBree JB, Fluckiger SS, Lange H, Schmidt B, et al: Cyclosporine pharmacokinetics and variability from a microemulsion formulation-multicenter investigation in kidney transplant patients. Transplantation 1994;58:658-663.
16. Kahan BD, Dunn J, Gitts C, Van Buren D, Bombolt D, Pollak R, et al: Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjuction with fasting, low-fat meals, or high-fat meals. Transplantation 1995;59:505-511.
17. Barone G, Chang C, Choc G, Klein J, Marsh CL, Meligeni J, et al: The pharmacokinetics of microemulsion formulation of cyclosporine Neoral in primary renal allograft recipients. Transplantation 1996;61:875-880.
18. Wang CP, Burckart GJ, Ptachcinski RJ, Venkataramanan R, Schsinghammer T, Hakala T, et al: Cyclosporine metabolite concentrations in the blood of liver, heart, kidney and bone marrow transplant patients. Transplant Proc 1988;20:591-596.
19. Chan KKH, Wnuck K: Microcomputer based pharmacokinetic programs for calculating absorption rate. Comput Prog Biomed 1983;16:27-34.
20. Edwards DJ, Bellevue III FH, Woster PM: Identification of 6,7-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice. Drug Metab Dis 1996;24:1287-1290.
21. Schmiedlin-Ren P, Edwards DJ, Fitzsimmons ME, He K, Lown KS, Woster PM, et al: Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Drug Metab Dis 1997;25:1228-1233.
22. Lown KS, Mayo RR, Leichtman AB, Hsiao H, Turgeon DK, Schmiedlin-Ren P, et al: Role of intestinal P-glycoprotein (mdr 1) in interpatient variation in the oral bioavailability of cyclosporine. Clin Pharmacol Ther 1997;62:248-260.
23. Kronbach T, Fischer V, Meyer UA: Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interaction of cyclosporine with other drugs. Clin Pharmacol Ther 1988;43:630-635.
24. Rosano TG, Freed BM, Cerilli J, Lempert N: Immunosuppressive metabolites of cyclosporine in the blood of renal allograft recipients. Transplantation 1986;42:262-267.
25. Vickers AEM, Fischer V, Connors S, Fisher RL, Baldeck J, Maurer G, et al: Cyclosporin A metabolism in human liver, kidney, and intestine slices. Drug Metab Dis 1992;20:802-809.
26. Hollander AAMJ, van Rooij J, Lentjes EGWM, Arbouw F, van Bree JB, Schoemaker RC, et al: The effect of grapefruit juice on cyclosporine and prednisone metabolism in transplant patients. Clin Pharmacol Ther 1995;57:318-324.
27. Yee GC, Stanley DL, Pessa LJ, Costa TD, Beltz SE, Ruiz J, et al: Effect of grapefruit juice on blood cyclosporine concentration. Lancet 1995;345:955-956.